Skip to main content
Equibles
TRAW logo

TRAW · Traws Pharma, Inc.

Track TRAW — free

Use TRAW with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TRAW

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.57 -0.03 (-4.83%) At close · Aug 14
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about our ability to continue as a going concern through the one-year period after the date that the financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$8.78M
Shares
15.37M

Traws Pharma, Inc. Earnings Call Transcripts

Every quarterly earnings call for Traws Pharma, Inc. (TRAW) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲4.8% $66,000 −$6.24M '20 Q3 20-11-12 ▲90% $57,000 −$6.43M '20 Q4 21-03-11 ▲7.7% $56,000 −$4.71M '21 Q1 21-05-17 ▲1.8% $57,000 −$4.23M '21 Q2 21-08-12 ▼13.6% $57,000 −$3.45M '21 Q3 21-11-12 ▼1.8% $56,000 −$3.76M '21 Q4 22-03-17 ▲0% $56,000 −$4.12M '22 Q1 22-05-11 ▲0% $57,000 −$4.02M '22 Q2 22-08-11 ▲0% $57,000 −$5.40M '22 Q3 22-11-14 ▲0% $56,000 −$5.42M '22 Q4 23-03-16 ▲0% $56,000 −$5.78M '23 Q1 23-05-15 ▲0% $57,000 −$4.25M '23 Q2 23-08-10 ▲0% $57,000 −$4.74M '23 Q3 23-11-14 ▲0% $57,000 −$123.14M '24 Q2 24-08-15 ▲0% $56,000 −$29.92M '24 Q4 25-03-31 LATEST ▲4694.7% $2.73M −$915,000 '25 Q2 25-08-14
Earnings call
FY25 · Q2
2025-08-14
Traws Pharma, Inc. Q2 FY2025 Earnings Call
Positive tone COVID program (ratutrelvir) Influenza/bird flu program (tivoxavir marboxil) Public health positioning
Revenue
$2.73M
▲ 4694.7% YoY
Diluted EPS
$-0.11
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Traws Pharma, Inc. Q4 FY2024 Earnings Call
Revenue
$56,000*
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-08-15
Traws Pharma, Inc. Q2 FY2024 Earnings Call
Revenue
$57,000
▲ 0% YoY
Diluted EPS
$-20.52
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-11-14
Traws Pharma, Inc. Q3 FY2023 Earnings Call
Revenue
$57,000
▲ 0% YoY
Diluted EPS
$-5.64
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Traws Pharma, Inc. Q2 FY2023 Earnings Call
Revenue
$57,000
▲ 0% YoY
Diluted EPS
$-5.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Traws Pharma, Inc. Q1 FY2023 Earnings Call
Revenue
$56,000
▲ 0% YoY
Diluted EPS
$-7.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Traws Pharma, Inc. Q4 FY2022 Earnings Call
Revenue
$56,000*
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Traws Pharma, Inc. Q3 FY2022 Earnings Call
Revenue
$57,000
▲ 0% YoY
Diluted EPS
$-6.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Traws Pharma, Inc. Q2 FY2022 Earnings Call
Revenue
$57,000
▲ 0% YoY
Diluted EPS
$-4.75
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Traws Pharma, Inc. Q1 FY2022 Earnings Call
Revenue
$56,000
▲ 0% YoY
Diluted EPS
$-5.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-17
Traws Pharma, Inc. Q4 FY2021 Earnings Call
Revenue
$56,000*
▼ 1.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Traws Pharma, Inc. Q3 FY2021 Earnings Call
Revenue
$57,000
▼ 13.6% YoY
Diluted EPS
$-5.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Traws Pharma, Inc. Q2 FY2021 Earnings Call
Revenue
$57,000
▲ 1.8% YoY
Diluted EPS
$-6.75
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Traws Pharma, Inc. Q1 FY2021 Earnings Call
Revenue
$56,000
▲ 7.7% YoY
Diluted EPS
$-8.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
Traws Pharma, Inc. Q4 FY2020 Earnings Call
Revenue
$57,000*
▲ 90% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Traws Pharma, Inc. Q3 FY2020 Earnings Call
Revenue
$66,000
▲ 4.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-12
Traws Pharma, Inc. Q2 FY2020 Earnings Call
Revenue
$56,000
▼ 97.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Traws Pharma, Inc. Q1 FY2020 Earnings Call
Revenue
$52,000
▼ 23.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-24
Traws Pharma, Inc. Q4 FY2019 Earnings Call
Revenue
$30,000*
▼ 49.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–19 of 19 earnings calls
Key facts CIK 1130598 CUSIP 68232V884 13F (30d) 39 filings 38 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)